Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Champions Oncology, Inc. - Common Stock (NQ:CSBR)

5.810 -0.030 (-0.51%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Champions Oncology, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Champions Oncology to Announce Second Quarter Financial Results on Monday, December 13, 2021
HACKENSACK, NJ / ACCESSWIRE / December 6, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), leaders in transformative technology solutions utilized in oncology drug discovery and development will report... 
From Champions Oncology, Inc.
Via AccessWire
Champions Oncology Expands Global Biomarker Capabilities with Opening of European Laboratory at OpenZone Life Sciences Campus
HACKENSACK, NJ / ACCESSWIRE / October 20, 2021 / Champions Oncology (NASDAQ:CSBR), a technology-enabled research organization announced the opening of a European laboratory located in the renowned... 
From Champions Oncology, Inc.
Via AccessWire
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Stealth BioTherapeutics (NASDAQ: 
Via Benzinga
Champions Oncology Reports Record Quarterly Revenue of $11.3 Million
HACKENSACK, NJ / ACCESSWIRE / September 13, 2021 / Champions Oncology, Inc. (Nasdaq:CSBR), leaders in transformative technology solutions utilized in drug discovery and development, today announced its... 
From Champions Oncology, Inc.
Via AccessWire
Topics Earnings
Exposures Financial
Earnings Scheduled For September 13, 2021
Companies Reporting Before The Bell • Optical Cable (NASDAQ:OCC) is expected to report earnings for its third quarter. • NAPCO Security (NASDAQ:NSSC) is estimated... 
Via Benzinga
Champions Oncology to Announce First Quarter Financial Results on Monday, September 13, 2021
HACKENSACK, NJ / ACCESSWIRE / September 2, 2021 / Champions Oncology, Inc. (CSBR), leaders in transformative technology solutionsutilized in oncology drug discovery and development will report its... 
From Champions Oncology, Inc.
Via AccessWire
Champions Oncology Announces an Expanded Corporate Strategy to Include Drug Discovery and Development
HACKENSACK, NJ / ACCESSWIRE / July 26, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology solutions provider that is transforming drug discovery through innovative... 
From Champions Oncology, Inc.
Via AccessWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Champions Oncology Reports Quarterly Revenue of $10.6 Million
Record Annual Revenue of $41 Million HACKENSACK, NJ / ACCESSWIRE / July 22, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), engaged in creating transformative technology solutions to be utilized in drug... 
From Champions Oncology, Inc.
Via AccessWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 22, 2021
HACKENSACK, NJ / ACCESSWIRE / July 14, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology solutions provider engaged in transforming drug discovery through innovative... 
From Champions Oncology, Inc.
Via AccessWire
Earnings Scheduled For July 22, 2021
Companies Reporting Before The Bell • Champions Oncology, Inc. - Common Stock (NASDAQ:CSBR) is estimated to report earnings for its fourth quarter. • MarineMax,... 
Via Benzinga
Champions Oncology and BGI Americas Announce a Strategic Partnership to Provide Mass Spectrometry Proteomics, Metabolomics, and Multi-Omic Data Analysis Solutions
HACKENSACK, NJ / ACCESSWIRE / June 15, 2021 / Champions Oncology (NASDAQ:CSBR), a technology-enabled research organization announced today that they have entered into a strategic partnership with BGI... 
From Champions Oncology, Inc.
Via AccessWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Biotech Stocks Wall Street Predicts Will Rally By 45% Or More
Wall Street analysts expect the biotech industry to grow significantly soon, with the biotech stocks Organogenesis (ORGO​​​​​​​), BioDelivery Sciences (BDSI) and Champions Oncology (CSBR) gaining more... 
Via Talk Markets
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.